ZIKV |
NPCs |
AKT-mTORC pathway inhibition |
Human fetal NSCs |
[36] |
STING cleavage |
Human fibroblasts |
[37] |
SEPTIN2 cleavage |
NPCs obtained from human H9 ESC-derived embryoid bodies |
[38] |
Centrosomal aberration |
Human neocortical NES cells |
[23] |
pTBK1 relocation |
Human neocortical NES cells |
[23] |
Proliferation impairment |
Human iPSC-derived forebrain organoids |
[39,40] |
Radial scaffold disorganization and architectural impairment |
Human organotypic fetal brain slices, post-mortem fetal brain samples |
[23] |
Cell death |
Human iPSC-derived forebrain organoids |
[39,40] |
Neuronal progeny/Immune cells |
Acute flaccid paralysis: (i) damage of motor neurons, (ii) Guillan–Barrè syndrome |
/ |
[41] |
Meningoencephalitis |
/ |
[42,43] |
T. gondii
|
NPCs |
Gliogenesis induction |
Mouse NPCs |
[44] |
Neurogenesis impairment |
Mouse NPCs |
[44] |
ER stress dependent apoptosis |
Mouse NSCs |
[45] |
Neuronal progeny |
Apoptosis |
/ |
[46] |
Neurotransmitter metabolism alteration |
Neural cells in mouse brain tissue |
[46,47] |
Neuroinflammation |
/ |
[48,49,50] |
Synaptic modification |
Mouse model |
[46,51] |
Behavioral alterations and psychiatric diseases |
Primary human temporal-lobe NSC lines |
[46,52,53,54] |
Rubella Virus |
NPCs |
Cell death |
Autoptic fetal tissue |
[55] |
Neuronal progeny |
Cell death |
Autoptic fetal tissue |
[55,56,57] |
CMV |
NPCs |
Neurogenesis impairment |
Human iPSC-derived brain organoids |
[58] |
Migration impairment |
Human iPSC-derived brain organoids |
[58] |
pTBK1 relocation |
Human neocortical NES cells |
[23] |
Proliferation impairment |
Human fetal brain-derived NPCs; human fetal NES cells; hNPCs |
[59,60,61] |
Cell death |
Primary human neuronal cell cultures; human fetal NES cells; hNPCs; human iPSC-derived brain organoids |
[58,59,61,62,63] |
Dysregulation of genes involved in multipotency, modulation of cellular excitability and calcium signaling |
Human iPSC-derived NSCs; hNPCs; human iPSC-derived brain organoids |
[58,64,65] |
SOX4, DCX, Nestin, SOX2 and GFAP proteasomal degradation |
Human fetal brain-derived NPCs; hNPCs |
[60,64] |
Neuronal progeny |
Apoptosis |
Human iPSC-derived NSCs |
[65] |
Downregulation of NMDA receptor |
Human iPSC-derived NSCs |
[65] |
HSV |
NPCs |
Proliferation surge (in acute phase) |
Mouse NSCs |
[66] |
Proliferation impairment (in chronic phase) |
Mouse NSCs |
[66] |
Neurogenesis impairment (in chronic phase) |
Mouse NSCs |
[66] |
APP fragmentation |
Mouse adult hippocampal NSCs |
[67] |
Gliogenesis induction |
Mouse adult hippocampal NSCs |
[67] |
Neuronal progeny |
G1 re-entry stimulated apoptosis |
Cerebellar granule cells; rat dorsal root ganglion neurons; human neuronal cell line; rat sympathetic neurons |
[68,69,70,71] |
Golgi apparatus remodeling |
Mouse cortical neurons |
[72] |
Changes in architecture and functional activity |
Human iPSC-derived neurons |
[73] |
Decrease of synaptic transmission |
Mouse cortical neurons |
[74] |
Accumulation of APP fragments |
Primary cultures of cortical neurons from rat embryos; mouse brains |
[75,76,77] |
Increase of intracellular calcium |
Rat cortical neurons |
[77] |
Increase of Tau phosphorylation and cleavage |
Mouse fetal neurons; AD brain specimens |
[78,79] |
Neuroinflammation |
Human brain organoids; mouse models |
[80,81] |
CoxB |
NPCs |
Cell death |
Neonatal mice brain; mouse cortical NPCs |
[82,83,84] |
Migration and neurogenesis impairment |
Neonatal mice central nervous system |
[85] |